Go Pro

Bodycote (LON:BOY) Price Target Raised to GBX 933

Bodycote logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Berenberg raised Bodycote’s price target to GBX 933 from GBX 900 while maintaining a “hold” rating, implying 1.74% downside from the current price.
  • Analyst sentiment is broadly positive, with three Buy and three Hold ratings; the stock has a “Moderate Buy” consensus and an average target price of GBX 881.33.
  • Bodycote shares opened at GBX 949.50 and are near their 52-week high of GBX 958. The company reported quarterly EPS of GBX 18.10, with a 7.87% net margin and 9.30% return on equity.
  • Five stocks we like better than Bodycote.

Bodycote (LON:BOY - Get Free Report) had its target price upped by equities research analysts at Berenberg Bank from GBX 900 to GBX 933 in a research report issued to clients and investors on Friday, London Stock Exchange reports. The firm currently has a "hold" rating on the stock. Berenberg Bank's target price suggests a potential downside of 1.74% from the company's current price.

Other equities analysts have also recently issued reports about the stock. Royal Bank Of Canada lifted their target price on shares of Bodycote from GBX 750 to GBX 950 and gave the company a "sector perform" rating in a report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a GBX 960 target price on shares of Bodycote in a research note on Thursday, August 6th. Finally, Jefferies Financial Group restated a "buy" rating and set a GBX 900 price target on shares of Bodycote in a research note on Wednesday, July 29th. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Bodycote presently has an average rating of "Moderate Buy" and a consensus target price of GBX 881.33.

Get Our Latest Analysis on Bodycote

Bodycote Stock Down 0.3%

Shares of LON:BOY opened at GBX 949.50 on Friday. The firm's 50 day moving average price is GBX 786.37 and its 200 day moving average price is GBX 737.20. The stock has a market cap of £1.61 billion, a price-to-earnings ratio of 28.26, a price-to-earnings-growth ratio of 1.44 and a beta of 1.35. Bodycote has a fifty-two week low of GBX 585 and a fifty-two week high of GBX 958. The company has a quick ratio of 0.74, a current ratio of 1.12 and a debt-to-equity ratio of 35.03.

Bodycote (LON:BOY - Get Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported GBX 18.10 earnings per share (EPS) for the quarter. Bodycote had a net margin of 7.87% and a return on equity of 9.30%. As a group, equities research analysts predict that Bodycote will post 54.0540541 earnings per share for the current fiscal year.

About Bodycote

(Get Free Report)

The leading provider of heat treatment and specialist thermal processing services worldwide. Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process. Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.

Featured Stories

Analyst Recommendations for Bodycote (LON:BOY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Bodycote Right Now?

Before you consider Bodycote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.

While Bodycote currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines